Charpentier F - Search Results

1

Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation.

Demolombe S, Lande G, Charpentier F, van Roon MA, van den Hoff MJ, Toumaniantz G, Baro I, Guihard G, Le Berre N, Corbier A, de Bakker J, Opthof T, Wilde A, Moorman AF, Escande D. Demolombe S, et al. Among authors: charpentier f. Cardiovasc Res. 2001 May;50(2):314-27. doi: 10.1016/s0008-6363(01)00231-0. Cardiovasc Res. 2001. PMID: 11334835

2

Long QT: Time to cut cholesterol?

Li J, Charpentier F, Maguy A. Li J, et al. Among authors: charpentier f. Int J Cardiol Heart Vasc. 2023 Jan 29;45:101179. doi: 10.1016/j.ijcha.2023.101179. eCollection 2023 Apr. Int J Cardiol Heart Vasc. 2023. PMID: 36793332 Free PMC article. No abstract available.

3

KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane.

Loussouarn G, Charpentier F, Mohammad-Panah R, Kunzelmann K, Baró I, Escande D. Loussouarn G, et al. Among authors: charpentier f. Mol Pharmacol. 1997 Dec;52(6):1131-6. doi: 10.1124/mol.52.6.1131. Mol Pharmacol. 1997. PMID: 9396783

4

A dominant negative isoform of the long QT syndrome 1 gene product.

Demolombe S, Baró I, Péréon Y, Bliek J, Mohammad-Panah R, Pollard H, Morid S, Mannens M, Wilde A, Barhanin J, Charpentier F, Escande D. Demolombe S, et al. Among authors: charpentier f. J Biol Chem. 1998 Mar 20;273(12):6837-43. doi: 10.1074/jbc.273.12.6837. J Biol Chem. 1998. PMID: 9506986 Free article.

5

Amiodarone reduces transmural heterogeneity of repolarization in the human heart.

Drouin E, Lande G, Charpentier F. Drouin E, et al. Among authors: charpentier f. J Am Coll Cardiol. 1998 Oct;32(4):1063-7. doi: 10.1016/s0735-1097(98)00330-1. J Am Coll Cardiol. 1998. PMID: 9768733 Free article.

6

Adult KCNE1-knockout mice exhibit a mild cardiac cellular phenotype.

Charpentier F, Merot J, Riochet D, Le Marec H, Escande D. Charpentier F, et al. Biochem Biophys Res Commun. 1998 Oct 29;251(3):806-10. doi: 10.1006/bbrc.1998.9554. Biochem Biophys Res Commun. 1998. PMID: 9790991

7

Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.

Merot J, Charpentier F, Poirier JM, Coutris G, Weissenburger J. Merot J, et al. Among authors: charpentier f. Cardiovasc Res. 1999 Nov;44(2):303-14. doi: 10.1016/s0008-6363(99)00232-1. Cardiovasc Res. 1999. PMID: 10690307

8

Differential expression of KvLQT1 isoforms across the human ventricular wall.

Péréon Y, Demolombe S, Baró I, Drouin E, Charpentier F, Escande D. Péréon Y, et al. Among authors: charpentier f. Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H1908-15. doi: 10.1152/ajpheart.2000.278.6.H1908. Am J Physiol Heart Circ Physiol. 2000. PMID: 10843888 Free article.

9

Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part II: Pharmacological profile.

Lande G, Demolombe S, Bammert A, Moorman A, Charpentier F, Escande D. Lande G, et al. Among authors: charpentier f. Cardiovasc Res. 2001 May;50(2):328-34. doi: 10.1016/s0008-6363(01)00232-2. Cardiovasc Res. 2001. PMID: 11334836

10

Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology.

Le Bouter S, Demolombe S, Chambellan A, Bellocq C, Aimond F, Toumaniantz G, Lande G, Siavoshian S, Baró I, Pond AL, Nerbonne JM, Léger JJ, Escande D, Charpentier F. Le Bouter S, et al. Among authors: charpentier f. Circ Res. 2003 Feb 7;92(2):234-42. doi: 10.1161/01.res.0000053185.75505.8e. Circ Res. 2003. PMID: 12574152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page